Cancer Diagnostics – Multimedia

In this infographic, we delve into the field of cancer genetics, highlight key milestones and explore how genomic approaches are transforming diagnosis and treatment of the disease in the clinic.

Understanding the integrity and quantity of your nucleic acid samples is critical for next-generation sequencing (NGS) and biobanking workflows.

Download this eBook to learn more about the impact of methylation and epigenetics in cancer.

Researchers at the Bruker-MUSC Clinical Glycomics Center of Excellence are developing and applying new technologies to map glycans in tissue and classify changes that occur during development of cancer.

Liquid biopsies are rapidly gaining traction and becoming a standard of care for cancer. They are an attractive alternative to invasive, painful, costly tissue biopsies and can facilitate real-time monitoring while providing insight into the disease state, even for tissues that are difficult to access, such as brain cancers.

With recent advances in cancer detection and prevention, a future where cancer can be cured is starting to feel within reach. One significant area of progress is early detection, which can go a long way toward eliminating cancer.

Agilent sample quality metrics are available for most RNA and DNA samples used in NGS, enabling you to know the concentration, size and integrity of your nucleic acid fragments.

Since many cancers don’t have symptoms early on, they may go unnoticed until they are at an advanced stage. But that is changing, thanks to a newer, non-invasive tool.

Download this listicle to explore various biomarkers, technological advances driving biomarker research and integrative approaches in disease research.

Next-generation sequencing (NGS) is an essential tool in molecular biology laboratories for the analysis of nucleic acid samples in numerous basic, translational and clinical research settings. Download this app compendium to discover systems that can be used to analyze genomic DNA, cell-free DNA, total RNA.